Patent details
EP2915525
Title:
Sublingual abuse-resistant tablets comprising buprenorphine and naloxone
Basic Information
- Publication number:
- EP2915525
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP151560240
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Sublingual abuse-resistant tablets comprising buprenorphine and naloxone
- French Title of Invention:
- Comprimés résistant aux abus à administration sublinguale contenant de la buprénorphine et de la naloxone
- German Title of Invention:
- Mißbrauchssichere Sublingualtabletten enthaltend Buprenorphin und Naloxon
- SPC Number:
-
Dates
- Filing date:
- 18/09/2012
- Grant date:
- 11/08/2021
- EP Publication Date:
- 09/09/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/08/2021
- EP B1 Publication Date:
- 11/08/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 18/09/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/08/2021
-
-
- Name:
- Orexo AB
- Address:
- Box 303, 751 05 Uppsala, Sweden (SE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 19/08/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- Fischer, Andreas
- Address:
- Sweden (SE)
Priority
- Priority Number:
- 201161536180 P
- Priority Date:
- 19/09/2011
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 9/00;
A61K 31/485;
A61K 9/20;
A61K 31/4748;
A61P 25/04;
A61P 25/30;
A61P 25/36;
Publication
European Patent Bulletin
1
- Issue number:
- 202132
- Publication date:
- 11/08/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202137
- Publication date:
- 15/09/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 15
- Annual Fee Amount:
- 213 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 23/09/2025
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 198 Euro
- Payer:
- IPIFY SAS